indomethacin has been researched along with Sclerosis, Systemic in 16 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with progressive systemic sclerosis (PSS) lymphocyte responses to phytohaemagglutinin (PHA) are abnormal (27." | 1.27 | Monocyte-induced inhibition of lymphocyte response to phytohaemagglutinin in progressive systemic sclerosis. ( Fuzesi, L; Joachim, C; Kazanjian-Aram, S; Lockshin, MD; Markenson, JA; Ordene, M, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (87.50) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, CY | 1 |
| Hsu, WL | 1 |
| Tsai, MH | 1 |
| Chai, CY | 1 |
| Yen, CJ | 1 |
| Chen, CH | 1 |
| Lu, JH | 1 |
| Yu, HS | 1 |
| Yoshioka, T | 1 |
| De Benedetti, F | 1 |
| Profumo, A | 1 |
| Lockshin, MD | 1 |
| Markenson, JA | 1 |
| Fuzesi, L | 1 |
| Kazanjian-Aram, S | 1 |
| Joachim, C | 1 |
| Ordene, M | 1 |
| Marrakchi, H | 1 |
| Fazaa, B | 1 |
| Gorgi, Y | 1 |
| Jellouli, A | 1 |
| Mokhtar, I | 1 |
| Kamoun, MR | 1 |
| Alcocer-Varela, J | 1 |
| Martinez-Cordero, E | 1 |
| Alarcon-Segovia, D | 1 |
| Sandborg, CI | 1 |
| Berman, MA | 1 |
| Andrews, BS | 1 |
| Friou, GJ | 1 |
| Henkind, P | 1 |
| Gold, DH | 1 |
| Thompson, M | 1 |
| Percy, JS | 1 |
| Emmrich, R | 1 |
| Klein, G | 2 |
| Fellner, S | 1 |
| Fellner, R | 1 |
| Kerl, H | 1 |
| Sandhofer, M | 1 |
| Treske, U | 1 |
| Fusco, FA | 1 |
| Azzolini, A | 1 |
| Dolcino, G | 1 |
| Haberman, JD | 1 |
| Ehrlich, GE | 1 |
| Levenson, C | 1 |
| Bartoletti, L | 1 |
| Biddau, A | 1 |
| Morace, G | 1 |
| Doni, A | 1 |
| Reicher, E | 1 |
| Reipert, D | 1 |
| Kowalczewska, J | 1 |
2 reviews available for indomethacin and Sclerosis, Systemic
| Article | Year |
|---|---|
[Antiphospholipid antibodies and systemic scleroderma. Apropos of a case with review of the literature].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Ar | 1995 |
Ocular manifestations of rheumatic disorders. Natural and iatrogenic.
Topics: Adrenal Cortex Hormones; Arteritis; Arthritis, Juvenile; Arthritis, Rheumatoid; Chloroquine; Conjunc | 1973 |
1 trial available for indomethacin and Sclerosis, Systemic
| Article | Year |
|---|---|
[Indomethacin in rheumatic diseases with special reference to ophthalmologic studies].
Topics: Allopurinol; Arthritis, Rheumatoid; Azathioprine; Blood Cells; Capsules; Clinical Trials as Topic; E | 1972 |
13 other studies available for indomethacin and Sclerosis, Systemic
| Article | Year |
|---|---|
A potential new approach for treating systemic sclerosis: Dedifferentiation of SSc fibroblasts and change in the microenvironment by blocking store-operated Ca2+ entry.
Topics: Boron Compounds; Calcium Channel Blockers; Calcium Signaling; Cell Dedifferentiation; Cells, Culture | 2019 |
[Contribution to anti-inflammatory therapy: results obtained with indomethacin].
Topics: Adult; Aged; Arthritis, Rheumatoid; Female; Humans; Hydrarthrosis; Indomethacin; Middle Aged; Osteoa | 1967 |
Monocyte-induced inhibition of lymphocyte response to phytohaemagglutinin in progressive systemic sclerosis.
Topics: Dinoprostone; Humans; Indomethacin; Lupus Erythematosus, Systemic; Lymphocyte Activation; Monocytes; | 1983 |
Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma.
Topics: Adult; Cell Division; Female; Humans; Indomethacin; Interleukin-1; Middle Aged; Monocytes; Rosette F | 1985 |
Interleukin-1 production by mononuclear cells from patients with scleroderma.
Topics: Blood Cell Count; Cells, Cultured; Concanavalin A; Humans; Indomethacin; Interleukin-1; Interleukin- | 1985 |
Further experience with indomethacin in the treatment of rheumatic disorders.
Topics: Aged; Arthritis, Reactive; Arthritis, Rheumatoid; Female; Gout; Humans; Indomethacin; Male; Middle A | 1966 |
[Hydroxyproline excretion in urine in chronic connective tissue disease].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Collagen | 1970 |
[Treatment of "collagen and autoimmune" diseases (author's transl)].
Topics: Adolescent; Adult; Aminobenzoates; Azathioprine; Chloroquine; Cyclophosphamide; Dermatomyositis; Dex | 1973 |
[Indomethacin and hematopoiesis. Antipyretic and antiphlogistic effects in hemoblastoses and various uncommon diseases].
Topics: Arthritis, Infectious; Arthritis, Rheumatoid; Dermatomyositis; Female; Hematologic Diseases; Hematop | 1968 |
[Clinical observations on the treatment of rheumatic diseases and other morbid states with indomethacin].
Topics: Anemia, Hemolytic, Autoimmune; Arthritis, Rheumatoid; Asthma; Crohn Disease; Dexamethasone; Hodgkin | 1966 |
Thermography in rheumatic diseases.
Topics: Adolescent; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoi | 1968 |
[Thrombopenic purpura during scleroderma treated with indomethacin].
Topics: Aged; Female; Humans; Indomethacin; Purpura, Thrombocytopenic; Scleroderma, Systemic | 1968 |
[Results of the treatment of juvenile rheumatoid arthritis with indomethacine].
Topics: Adolescent; Adult; Arthritis, Juvenile; Child; Headache; Humans; Indomethacin; Male; Scleroderma, Sy | 1969 |